Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.2K
Overview
80.2K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

656
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
656
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

885
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
885

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zinc-polydopamine nanozyme promotes mitochondrial biogenesis and alleviates inflammation and muscle atrophy during the perioperative period of surgery.

Journal of materials science. Materials in medicine·2026
Same author

Global Research Trends and Thematic Evolution in Robotic Surgery for Obstructive Sleep Apnoea: A Bibliometric and Visualisation Study.

Journal of robotic surgery·2026
Same author

Theoretical design of diatomic catalysts for selective hydrodeoxygenation of furfural to 2-methylfuran.

Physical chemistry chemical physics : PCCP·2026
Same author

CoFe alloy nanoparticles embedded in carbon nanofibers for efficient synthesis of ammonia from nitrate reduction.

Chemical communications (Cambridge, England)·2026
Same author

Effects of microhabitat construction on water-ecosystem coupling in Urban Rivers: integrated assessment of water quality and biodiversity responses in Beijing, China.

Water science and technology : a journal of the International Association on Water Pollution Research·2026
Same author

Development and validation of a prognostic nomogram incorporating preoperative NLR, CEA and CA19-9 for overall survival in colorectal cancer.

Oncology letters·2026

Related Experiment Video

Updated: Feb 5, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.2K

Exploring enterovirus pathogenesis and cancer therapy potential through reverse genetics.

Shijin Wang1,2, Qing Yu2,3, Junfeng Zhou4

  • 1Cancer Center, The First Hospital of Jilin University, Changchun 130021 China.

Biosafety and Health
|February 4, 2026
PubMed
Summary

Oncolytic enteroviruses (EVs) show promise for cancer treatment due to tumor-specific targeting. Reverse genetics advances understanding of EV infection and aids development of novel immunotherapies.

Keywords:
Enterovirus (EV)Oncolytic virus (OV)PathogenesisReverse geneticsTumor immunity

More Related Videos

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

17.2K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K

Related Experiment Videos

Last Updated: Feb 5, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.2K
Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

17.2K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Oncolytic viruses are emerging as potent anticancer agents.
  • Enteroviruses (EVs) exhibit specific tropism for tumor cells, making them attractive candidates for oncolysis.
  • Reverse genetics has become a powerful tool for studying viral mechanisms and developing therapeutic applications.

Purpose of the Study:

  • To review the progress and potential clinical applications of reverse genetics in the development of oncolytic enteroviruses.
  • To explore the characteristics of EVs and the role of reverse genetics in understanding their infection mechanisms and oncolytic potential.
  • To highlight specific enteroviruses with oncolytic roles and their significance in cancer immunotherapy.

Main Methods:

  • Review of scientific literature on oncolytic enteroviruses and reverse genetics.
  • Analysis of studies investigating enterovirus tropism and pathogenesis.
  • Discussion of specific enterovirus serotypes with demonstrated oncolytic activity.

Main Results:

  • Reverse genetics has significantly advanced the understanding of enterovirus infection mechanisms and pathogenesis.
  • Specific enteroviruses, including EV-A71, CV-B3, Echo-7, CV-A21, and poliovirus, have shown oncolytic potential.
  • The application of reverse genetics facilitates the development of engineered oncolytic enteroviruses for cancer therapy.

Conclusions:

  • Oncolytic enteroviruses engineered using reverse genetics offer a promising avenue for cancer treatment.
  • The tumor-specific tropism of certain EVs enhances their potential as targeted oncolytic agents.
  • Further research and clinical translation of oncolytic EVs hold significant promise for cancer immunotherapy.